Abstract
Several lines of evidence show that blood pressure (BP) control in treated hypertensive patients is largely unsatisfactory and that this depends on a variety of factors, such as the poor patient’s compliance, insufficient use of combination drug treatment as well as true difficulties in achieving well controlled BP. This review article will be focused on the main features of BP control by discussing the data obtained in clinical trials as well as the results available in clinical practice. The paper will also discuss the possible factors responsible for these findings as well as the favourable outcome on cardiovascular risk profile of an effective control of elevated BP. The possible approaches for controlling elevated BP values will be highlighted.
Keywords: Hypertension, antihypertensive treatment, blood pressure control, treatment compliance, clinical trials, cardiovascular risk, ACE-inhibitor, beta-blocker, metabolic disorders, cerebrovascular disease
Current Vascular Pharmacology
Title:Blood Pressure Control and Antihypertensive Treatment
Volume: 10 Issue: 4
Author(s): Guido Grassi, Gino Seravalle, Fosca Quarti Trevano, Raffaella Dell’Oro and Giuseppe Mancia
Affiliation:
Keywords: Hypertension, antihypertensive treatment, blood pressure control, treatment compliance, clinical trials, cardiovascular risk, ACE-inhibitor, beta-blocker, metabolic disorders, cerebrovascular disease
Abstract: Several lines of evidence show that blood pressure (BP) control in treated hypertensive patients is largely unsatisfactory and that this depends on a variety of factors, such as the poor patient’s compliance, insufficient use of combination drug treatment as well as true difficulties in achieving well controlled BP. This review article will be focused on the main features of BP control by discussing the data obtained in clinical trials as well as the results available in clinical practice. The paper will also discuss the possible factors responsible for these findings as well as the favourable outcome on cardiovascular risk profile of an effective control of elevated BP. The possible approaches for controlling elevated BP values will be highlighted.
Export Options
About this article
Cite this article as:
Grassi Guido, Seravalle Gino, Quarti Trevano Fosca, Dell’Oro Raffaella and Mancia Giuseppe, Blood Pressure Control and Antihypertensive Treatment, Current Vascular Pharmacology 2012; 10 (4) . https://dx.doi.org/10.2174/157016112800812719
DOI https://dx.doi.org/10.2174/157016112800812719 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Advances in Retrograde Technique for Coronary Chronic Total Occlusions
Current Cardiology Reviews Biologic and Novel Therapy of the Inflammatory Bowel Diseases
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Connexin Modulators and Their Potential Targets under the Magnifying Glass
Current Medicinal Chemistry Perspective Methods for Producing Composite Materials Based on Carbon, Silicon and Silicon Carbide: Progress and Challenges
Recent Patents on Materials Science Medicinal Perspective of Indole Derivatives: Recent Developments and Structure-Activity Relationship Studies
Current Drug Targets Current Treatment Concepts of Philadelphia-Negative MPN
Current Cancer Drug Targets A Review of Patents on Therapeutic Potential and Delivery of Hydroge n Sulfide
Recent Patents on Drug Delivery & Formulation Venous Thromboembolism Risk and Adequacy of Prophylaxis in High Risk Pregnancy in the Arabian Gulf
Current Vascular Pharmacology Hematopoietic Cytokines - on the Verge of Conquering Neurology
Current Molecular Medicine Cardiovascular Imaging in Thromboembolic Risk Stratification for Atrial Fibrillation: Recent Patents and Current Practice
Recent Patents on Medical Imaging Pharmacological Management of Type 2 Diabetes Mellitus: An Update
Current Diabetes Reviews Cerebral Arachidonate Cascade in Dementia: Alzheimers Disease and Vascular Dementia
Current Neuropharmacology Oxidative Stress During Myocardial Ischaemia and Heart Failure
Current Pharmaceutical Design New Strategy for Synthesis of Anticancer Active Piperastrol, Enastron Using Ammonium Sulfocyanate
Letters in Organic Chemistry Anti-Diabetic Compounds and their Patent Information: An Update
Recent Patents on Inflammation & Allergy Drug Discovery Fitness or Fatness: The Debate Continues for AMP-Activated Protein Kinase in Heart Function
Current Cardiology Reviews Hemodynamic Forces Regulate Embryonic Stem Cell Commitment to Vascular Progenitors
Current Cardiology Reviews Therapeutic Effects of Progesterone in Animal Models of Neurological Disorders
CNS & Neurological Disorders - Drug Targets Combining Stem Cells and Tissue Engineering in Cardiovascular Repair - a Step Forward to Derivation of Novel Implants with Enhanced Function and Self-Renewal Characteristics
Recent Patents on Cardiovascular Drug Discovery Cord Blood as Diagnostic Window for Preeclampsia
Recent Patents on Biomarkers